Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Endocytosis,11/252,0.0026884352338258,0.2278754739238744,0,0,2.852623714159918,16.88409769218427,RAB5B;EHD4;SMURF1;NEDD4;VTA1;WIPF3;ARAP3;ARRB2;ARAP1;RAB22A;SH3GL1
GO_Biological_Process_2021,MAPK signaling pathway,12/294,0.0030414433288307,0.2278754739238744,0,0,2.662457103637612,15.430065393234065,CSF1R;RPS6KA6;RAP1A;PLA2G4C;NFATC3;TGFA;KRAS;ARRB2;CRK;DUSP7;MAP4K4;MAP3K5
GO_Biological_Process_2021,Neurotrophin signaling pathway,7/119,0.0031649371378315,0.2278754739238744,0,0,3.882142857142857,22.344147166658534,RPS6KA6;RAP1A;MATK;KRAS;CRK;SH2B3;MAP3K5
GO_Biological_Process_2021,Yersinia infection,7/137,0.006812935522247,0.2747064259938622,0,0,3.3415384615384616,16.670708798785434,RPS6KA6;WIPF3;NFATC3;ITGA5;TICAM1;CRK;WASF2
GO_Biological_Process_2021,Chronic myeloid leukemia,5/76,0.007630734055385,0.2747064259938622,0,0,4.355755987026258,21.23679858326369,CTBP2;KRAS;CRK;DDB2;BCL2L1
GO_Biological_Process_2021,Pancreatic cancer,5/76,0.007630734055385,0.2747064259938622,0,0,4.355755987026258,21.23679858326369,RALB;TGFA;KRAS;DDB2;BCL2L1
GO_Biological_Process_2021,Ras signaling pathway,9/232,0.0131778393152497,0.388251416176268,0,0,2.5085602945600938,10.860106137222692,CSF1R;RAB5B;RAP1A;RALB;PLA2G4C;TGFA;KRAS;RASAL2;BCL2L1
GO_Biological_Process_2021,Long-term depression,4/60,0.015867904698755,0.388251416176268,0,0,4.407457322551662,18.26210893549118,RYR1;PLA2G4C;ITPR2;KRAS
GO_Biological_Process_2021,Vascular smooth muscle contraction,6/133,0.0207974771799923,0.388251416176268,0,0,2.923004086514502,11.320571477564611,ACTA2;NPR2;PLA2G4C;ITPR2;MYH9;RAMP1
GO_Biological_Process_2021,Rap1 signaling pathway,8/210,0.0207981553259665,0.388251416176268,0,0,2.4564545626537178,9.513580724522669,CSF1R;DOCK4;RAP1A;RALB;MAGI3;ARAP3;KRAS;CRK
GO_Biological_Process_2021,Thyroid cancer,3/37,0.0214540761924821,0.388251416176268,0,0,5.433523879771344,20.874732747668112,NCOA4;KRAS;DDB2
GO_Biological_Process_2021,Long-term potentiation,4/67,0.0228694403753428,0.388251416176268,0,0,3.91634221822901,14.795759734634668,RPS6KA6;RAP1A;ITPR2;KRAS
GO_Biological_Process_2021,Lipid and atherosclerosis,8/215,0.0235391335870045,0.388251416176268,0,0,2.3965045078310103,8.984713442985974,CASP7;RAP1A;POU2F1;NFATC3;KRAS;TICAM1;MAP3K5;BCL2L1
GO_Biological_Process_2021,Renal cell carcinoma,4/69,0.0251644436410544,0.388251416176268,0,0,3.795452346395743,13.976082409684931,RAP1A;TGFA;KRAS;CRK
GO_Biological_Process_2021,Apoptosis,6/142,0.0275813873635645,0.3971719780353299,0,0,2.72831347728965,9.796320853421165,CASP7;ITPR2;KRAS;CTSC;MAP3K5;BCL2L1
GO_Biological_Process_2021,p53 signaling pathway,4/73,0.0301576200604444,0.4071278708159994,0,0,3.574696928265427,12.516149446258536,ZMAT3;SESN2;DDB2;BCL2L1
GO_Biological_Process_2021,Oxytocin signaling pathway,6/154,0.0386973189452592,0.4916835818927061,0,0,2.5055593568251795,8.148041342894825,RYR1;NPR2;PLA2G4C;NFATC3;ITPR2;KRAS
GO_Biological_Process_2021,Colorectal cancer,4/86,0.0501657815376745,0.6019893784520947,0,0,3.005982512655315,8.995168585399883,RALB;TGFA;KRAS;DDB2
GO_Biological_Process_2021,Herpes simplex virus 1 infection,13/498,0.0606834645336989,0.6443726617576534,0,0,1.6648917358956394,4.665166546466611,RNASEL;ZNF251;POU2F1;ZNF140;TICAM1;ZNF25;ZSCAN32;ZNF426;ITGA5;ZNF786;ZNF675;ZNF398;BCL2L1
GO_Biological_Process_2021,Hedgehog signaling pathway,3/56,0.0613865511783608,0.6443726617576534,0,0,3.4822854438989768,9.717542152554357,MOSMO;SMURF1;ARRB2
GO_Biological_Process_2021,Regulation of actin cytoskeleton,7/218,0.0634245210553482,0.6443726617576534,0,0,2.0502369668246447,5.654358217928686,GSN;MYH9;PIP4K2B;KRAS;ITGA5;CRK;WASF2
GO_Biological_Process_2021,Apelin signaling pathway,5/137,0.0708591418998441,0.6443726617576534,0,0,2.33557977248829,6.182422804092798,RYR1;ACTA2;ITPR2;KRAS;NRF1
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,4/97,0.071596962417517,0.6443726617576534,0,0,2.648948400622168,6.984489215321846,GSN;PLA2G4C;CRK;WASF2
GO_Biological_Process_2021,Phosphatidylinositol signaling system,4/97,0.071596962417517,0.6443726617576534,0,0,2.648948400622168,6.984489215321846,ITPR2;PIP4K2B;PI4KB;PIK3C2B
GO_Biological_Process_2021,Pentose phosphate pathway,2/30,0.0837060450197145,0.699326340342735,0,0,4.386160714285714,10.879626384858115,PGM2;PFKP
GO_Biological_Process_2021,GnRH secretion,3/64,0.0841781705968106,0.699326340342735,0,0,3.024358908474228,7.484742849043605,ITPR2;KRAS;ARRB2
GO_Biological_Process_2021,Galactose metabolism,2/31,0.0885604584645628,0.7084836677165026,0,0,4.234698275862069,10.265204260705508,PGM2;PFKP
GO_Biological_Process_2021,SNARE interactions in vesicular transport,2/33,0.0985097145603111,0.759932083750972,0,0,3.961088709677419,9.180219631999073,YKT6;BET1
GO_Biological_Process_2021,Adherens junction,3/71,0.1066304418694609,0.769353446660109,0,0,2.7120597455283053,6.070637208339281,FER;PTPRM;WASF2
GO_Biological_Process_2021,Non-small cell lung cancer,3/72,0.1100118305443847,0.769353446660109,0,0,2.672618236336377,5.898915759885027,TGFA;KRAS;DDB2
GO_Biological_Process_2021,Inositol phosphate metabolism,3/73,0.1134341559321288,0.769353446660109,0,0,2.634303627407076,5.73364807725181,PIP4K2B;PI4KB;PIK3C2B
GO_Biological_Process_2021,Mucin type O-glycan biosynthesis,2/36,0.1139782883940902,0.769353446660109,0,0,3.6110294117647057,7.842243380310247,GALNT1;ST6GALNAC3
GO_Biological_Process_2021,Glioma,3/75,0.1203981631724226,0.7869529160586701,0,0,2.5608672936259143,5.421230583913627,TGFA;KRAS;DDB2
GO_Biological_Process_2021,Pertussis,3/76,0.123938108498182,0.7869529160586701,0,0,2.5256580924979604,5.273505810908082,CASP7;ITGA5;TICAM1
GO_Biological_Process_2021,Bacterial invasion of epithelial cells,3/77,0.127515518805803,0.7869529160586701,0,0,2.4914004914004915,5.131082178245328,ITGA5;CRK;WASF2
GO_Biological_Process_2021,RNA degradation,3/79,0.1347792330138466,0.8013546019939809,0,0,2.425589836660617,4.861166190839427,PABPC1L;PFKP;DCP1B
GO_Biological_Process_2021,Platelet activation,4/124,0.1401775155611117,0.8013546019939809,0,0,2.050104821802935,4.028139625775648,RAP1A;P2RX1;PLA2G4C;ITPR2
GO_Biological_Process_2021,Ferroptosis,2/41,0.1409790503507929,0.8013546019939809,0,0,3.147275641025641,6.165966121472794,GCLC;NCOA4
GO_Biological_Process_2021,Purine metabolism,4/129,0.1550294683238906,0.8217679010182609,0,0,1.9675974842767296,3.667877296162279,DGUOK;NPR2;ADK;PGM2
GO_Biological_Process_2021,ErbB signaling pathway,3/85,0.1573783654291661,0.8217679010182609,0,0,2.247419527486811,4.155708846734893,TGFA;KRAS;CRK
GO_Biological_Process_2021,NOD-like receptor signaling pathway,5/181,0.1682481621909438,0.8217679010182609,0,0,1.7477416117006022,3.1150264989340704,RNASEL;ITPR2;TICAM1;MCU;BCL2L1
GO_Biological_Process_2021,Axon guidance,5/182,0.1708958398002682,0.8217679010182609,0,0,1.7377782530431838,3.0701346331183044,NRP1;PLXNA2;NFATC3;KRAS;SRGAP2
GO_Biological_Process_2021,PD-L1 expression and PD-1 checkpoint pathway in cancer,3/89,0.1730477951576432,0.8217679010182609,0,0,2.1424509732448787,3.758260609620149,NFATC3;KRAS;TICAM1
GO_Biological_Process_2021,Nucleotide excision repair,2/47,0.1749108034670763,0.8217679010182609,0,0,2.7268055555555555,4.754128576236293,POLD3;DDB2
GO_Biological_Process_2021,Amino sugar and nucleotide sugar metabolism,2/48,0.1806890463623418,0.8217679010182609,0,0,2.667391304347826,4.563847041654904,UXS1;PGM2
GO_Biological_Process_2021,GnRH signaling pathway,3/93,0.1891352777360122,0.8217679010182609,0,0,2.0468129571577847,3.4085428083229616,PLA2G4C;ITPR2;KRAS
GO_Biological_Process_2021,Ubiquitin mediated proteolysis,4/140,0.1896039697360634,0.8217679010182609,0,0,1.8074361820199776,3.00543696898661,SMURF1;NEDD4;UBE2E2;DDB2
GO_Biological_Process_2021,Calcium signaling pathway,6/240,0.1915379876726653,0.8217679010182609,0,0,1.5777345017851347,2.6074730922147027,RYR1;CYSLTR1;P2RX1;PTAFR;ITPR2;MCU
GO_Biological_Process_2021,Cysteine and methionine metabolism,2/50,0.1923280195400404,0.8217679010182609,0,0,2.555989583333333,4.213684115542283,AHCYL2;GCLC
GO_Biological_Process_2021,Spinocerebellar ataxia,4/143,0.1994330240492467,0.8217679010182609,0,0,1.768155287091082,2.8507557801246275,RYR1;ITPR2;MCU;MAP3K5
GO_Biological_Process_2021,Choline metabolism in cancer,3/98,0.2097499934497477,0.8217679010182609,0,0,1.938590991585547,3.0277669475920197,PLA2G4C;KRAS;WASF2
GO_Biological_Process_2021,mRNA surveillance pathway,3/98,0.2097499934497477,0.8217679010182609,0,0,1.938590991585547,3.0277669475920197,CPSF4;PABPC1L;WDR33
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,5/197,0.2124216705136379,0.8217679010182609,0,0,1.6007820715036802,2.479902719740527,MYO1D;CASP7;WIPF3;MYH9;WASF2
GO_Biological_Process_2021,Cell adhesion molecules,4/148,0.2161433050567799,0.8217679010182609,0,0,1.706324248777079,2.613770761860408,NLGN4Y;SELPLG;PTPRM;CD276
GO_Biological_Process_2021,Glutathione metabolism,2/57,0.2336928623999563,0.8217679010182609,0,0,2.229886363636364,3.2416919039730905,HPGDS;GCLC
GO_Biological_Process_2021,C-type lectin receptor signaling pathway,3/104,0.2350936023331012,0.8217679010182609,0,0,1.8228684937459263,2.6390971197382203,NFATC3;ITPR2;KRAS
GO_Biological_Process_2021,NF-kappa B signaling pathway,3/104,0.2350936023331012,0.8217679010182609,0,0,1.8228684937459263,2.6390971197382203,TICAM1;EDA2R;BCL2L1
GO_Biological_Process_2021,Toll-like receptor signaling pathway,3/104,0.2350936023331012,0.8217679010182609,0,0,1.8228684937459263,2.6390971197382203,IRF5;TLR7;TICAM1
GO_Biological_Process_2021,Endometrial cancer,2/58,0.2396541213797647,0.8217679010182609,0,0,2.189955357142857,3.128479462767984,KRAS;DDB2
GO_Biological_Process_2021,Nitrogen metabolism,1/17,0.2412158673422,0.8217679010182609,0,0,3.828271028037383,5.444042702738241,CA8
GO_Biological_Process_2021,Cellular senescence,4/156,0.2436196407212631,0.8217679010182609,0,0,1.6158556769281696,2.281825939640425,NFATC3;ITPR2;KRAS;MCU
GO_Biological_Process_2021,Notch signaling pathway,2/59,0.2456226281832826,0.8217679010182609,0,0,2.1514254385964917,3.020513005490481,MAML2;CTBP2
GO_Biological_Process_2021,VEGF signaling pathway,2/59,0.2456226281832826,0.8217679010182609,0,0,2.1514254385964917,3.020513005490481,PLA2G4C;KRAS
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,5/212,0.2567725599292206,0.8217679010182609,0,0,1.483640409027873,2.0171049298887174,NFATC3;ITPR2;KRAS;CRK;BCL2L1
GO_Biological_Process_2021,Arachidonic acid metabolism,2/61,0.2575743501696138,0.8217679010182609,0,0,2.078283898305085,2.819081672268644,HPGDS;PLA2G4C
GO_Biological_Process_2021,Hepatitis B,4/162,0.264715997368509,0.8217679010182609,0,0,1.554016399968155,2.065439678483374,NFATC3;KRAS;TICAM1;DDB2
GO_Biological_Process_2021,Glycosaminoglycan degradation,1/19,0.2654730495996998,0.8217679010182609,0,0,3.4025614399446176,4.512619724386027,HPSE
GO_Biological_Process_2021,Serotonergic synapse,3/113,0.2739984396054666,0.8217679010182609,0,0,1.672955257908236,2.165862862712892,PLA2G4C;ITPR2;KRAS
GO_Biological_Process_2021,Steroid biosynthesis,1/20,0.2773101610873619,0.8217679010182609,0,0,3.2233152975897688,4.134284425406205,SC5D
GO_Biological_Process_2021,Hepatocellular carcinoma,4/168,0.2861357847841622,0.8217679010182609,0,0,1.4967019481515569,1.8728063979183724,TGFA;KRAS;BCL2L1;DDB2
GO_Biological_Process_2021,Pantothenate and CoA biosynthesis,1/21,0.2889570968381459,0.8217679010182609,0,0,3.061993769470405,3.8013950096081177,PANK1
GO_Biological_Process_2021,Tight junction,4/169,0.2897312916212708,0.8217679010182609,0,0,1.4875547932151705,1.8427849100714724,RAP1A;NEDD4;MYH9;MAP3K5
GO_Biological_Process_2021,Acute myeloid leukemia,2/67,0.2934301053203825,0.8217679010182609,0,0,1.8858653846153848,2.312289363765586,CSF1R;KRAS
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,2/67,0.2934301053203825,0.8217679010182609,0,0,1.8858653846153848,2.312289363765586,PGM2;PFKP
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,2/68,0.2993903979309642,0.8217679010182609,0,0,1.8571969696969697,2.239792320276315,PLA2G4C;KRAS
GO_Biological_Process_2021,Mitophagy,2/68,0.2993903979309642,0.8217679010182609,0,0,1.8571969696969697,2.239792320276315,KRAS;BCL2L1
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",3/119,0.3002993541721016,0.8217679010182609,0,0,1.5859366554967032,1.9078428691196383,ITPR2;KRAS;CRK
GO_Biological_Process_2021,Sphingolipid signaling pathway,3/119,0.3002993541721016,0.8217679010182609,0,0,1.5859366554967032,1.9078428691196383,ACER2;KRAS;MAP3K5
GO_Biological_Process_2021,Influenza A,4/172,0.3005540008353825,0.8217679010182609,0,0,1.460766696615753,1.7560283106387502,CPSF4;RNASEL;TLR7;TICAM1
GO_Biological_Process_2021,Central carbon metabolism in cancer,2/70,0.3112852281565931,0.8311802034891029,0,0,1.802389705882353,2.1034710744620653,KRAS;PFKP
GO_Biological_Process_2021,Mismatch repair,1/23,0.3116925763084136,0.8311802034891029,0,0,2.7833474936278675,3.2446536880117733,POLD3
GO_Biological_Process_2021,Melanoma,2/72,0.3231374047698868,0.85119121256458,0,0,1.7507142857142857,1.9777427903955849,KRAS;DDB2
GO_Biological_Process_2021,alpha-Linolenic acid metabolism,1/25,0.3337032769256238,0.8684326242883704,0,0,2.551142263759086,2.7998864748963337,PLA2G4C
GO_Biological_Process_2021,Relaxin signaling pathway,3/129,0.3443436419283977,0.8718877224751813,0,0,1.459322286908494,1.5558056150657804,ACTA2;KRAS;ARRB2
GO_Biological_Process_2021,RNA transport,4/186,0.3515181481143438,0.8718877224751813,0,0,1.3474324417720644,1.4087324505220438,NUP188;NUP42;PABPC1L;PAIP1
GO_Biological_Process_2021,Pathways in cancer,10/531,0.3520909671494566,0.8718877224751813,0,0,1.178515182833801,1.230211584974266,CSF1R;CASP7;RALB;CTBP2;NCOA4;TGFA;KRAS;CRK;DDB2;BCL2L1
GO_Biological_Process_2021,Shigellosis,5/246,0.3633276495517176,0.8718877224751813,0,0,1.2721049255860832,1.287942932107383,ITPR2;ITGA5;CRK;WASF2;BCL2L1
GO_Biological_Process_2021,Chemokine signaling pathway,4/192,0.3734321356878398,0.8718877224751813,0,0,1.3040278335340558,1.2844921784902856,RAP1A;KRAS;ARRB2;CRK
GO_Biological_Process_2021,Transcriptional misregulation in cancer,4/192,0.3734321356878398,0.8718877224751813,0,0,1.3040278335340558,1.2844921784902856,CSF1R;LYL1;BCL2L1;DDB2
GO_Biological_Process_2021,Linoleic acid metabolism,1/29,0.3756417530158563,0.8718877224751813,0,0,2.186248331108144,2.140598098045785,PLA2G4C
GO_Biological_Process_2021,B cell receptor signaling pathway,2/81,0.3757072099997295,0.8718877224751813,0,0,1.5505537974683543,1.5179070977399745,NFATC3;KRAS
GO_Biological_Process_2021,Kaposi sarcoma-associated herpesvirus infection,4/193,0.3770807020557658,0.8718877224751813,0,0,1.297061661841536,1.2650191162229742,NFATC3;ITPR2;KRAS;TICAM1
GO_Biological_Process_2021,Autophagy,3/137,0.3794326199660511,0.8718877224751813,0,0,1.3716371122444204,1.3292236888119495,KRAS;BCL2L1;RAB33B
GO_Biological_Process_2021,Estrogen signaling pathway,3/137,0.3794326199660511,0.8718877224751813,0,0,1.3716371122444204,1.3292236888119495,ITPR2;TGFA;KRAS
GO_Biological_Process_2021,Base excision repair,1/33,0.4149481861763613,0.8739887965081903,0,0,1.9125778816199377,1.682306601391344,POLD3
GO_Biological_Process_2021,Fructose and mannose metabolism,1/33,0.4149481861763613,0.8739887965081903,0,0,1.9125778816199377,1.682306601391344,PFKP
GO_Biological_Process_2021,Gap junction,2/88,0.415419137113111,0.8739887965081903,0,0,1.4238372093023255,1.2507944281544954,ITPR2;KRAS
GO_Biological_Process_2021,Proteoglycans in cancer,4/205,0.4206329943064422,0.8739887965081903,0,0,1.2188741825463876,1.0555384272345134,ITPR2;KRAS;HPSE;ITGA5
GO_Biological_Process_2021,Phospholipase D signaling pathway,3/148,0.4269617140306898,0.8739887965081903,0,0,1.2668684466544158,1.07818224152025,RALB;PLA2G4C;KRAS
GO_Biological_Process_2021,Small cell lung cancer,2/92,0.4375404116557219,0.8739887965081903,0,0,1.3602777777777777,1.1243868500939918,DDB2;BCL2L1
GO_Biological_Process_2021,Th1 and Th2 cell differentiation,2/92,0.4375404116557219,0.8739887965081903,0,0,1.3602777777777777,1.1243868500939918,MAML2;NFATC3
GO_Biological_Process_2021,DNA replication,1/36,0.4428002048543613,0.8739887965081903,0,0,1.7483756119270135,1.4242907911469225,POLD3
GO_Biological_Process_2021,Starch and sucrose metabolism,1/36,0.4428002048543613,0.8739887965081903,0,0,1.7483756119270135,1.4242907911469225,PGM2
GO_Biological_Process_2021,Aldosterone-regulated sodium reabsorption,1/37,0.4517872799206606,0.8739887965081903,0,0,1.699723087573555,1.3505044912103314,KRAS
GO_Biological_Process_2021,mTOR signaling pathway,3/154,0.4523568121594121,0.8739887965081903,0,0,1.2161556187589528,0.9647567976851316,RPS6KA6;SESN2;KRAS
GO_Biological_Process_2021,Staphylococcus aureus infection,2/95,0.4538301813049912,0.8739887965081903,0,0,1.3161962365591398,1.039837409590303,SELPLG;PTAFR
GO_Biological_Process_2021,Prostate cancer,2/97,0.4645393597097985,0.8739887965081903,0,0,1.2883552631578947,0.9877935608599856,TGFA;KRAS
GO_Biological_Process_2021,Hepatitis C,3/157,0.4648815360489578,0.8739887965081903,0,0,1.192281073158816,0.9132547134651484,RNASEL;KRAS;TICAM1
GO_Biological_Process_2021,Inflammatory mediator regulation of TRP channels,2/98,0.4698474693059983,0.8739887965081903,0,0,1.2748697916666667,0.9629692896897628,PLA2G4C;ITPR2
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,4/219,0.4704694522974407,0.8739887965081903,0,0,1.138686558432061,0.8585972760502127,NRP1;NFATC3;KRAS;BCL2L1
GO_Biological_Process_2021,Hematopoietic cell lineage,2/99,0.4751240738306495,0.8739887965081903,0,0,1.261662371134021,0.9389030214382452,CSF1R;ITGA5
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,2/100,0.4803688098448648,0.8739887965081903,0,0,1.2487244897959184,0.9155661898313416,RPS6KA6;KRAS
GO_Biological_Process_2021,Bladder cancer,1/41,0.4863134613429943,0.8739887965081903,0,0,1.5294392523364486,1.1025756335879116,KRAS
GO_Biological_Process_2021,Homologous recombination,1/41,0.4863134613429943,0.8739887965081903,0,0,1.5294392523364486,1.1025756335879116,POLD3
GO_Biological_Process_2021,Longevity regulating pathway,2/102,0.4907613205060634,0.8739887965081903,0,0,1.223625,0.870973067053943,SESN2;KRAS
GO_Biological_Process_2021,Pancreatic secretion,2/102,0.4907613205060634,0.8739887965081903,0,0,1.223625,0.870973067053943,RAP1A;ITPR2
GO_Biological_Process_2021,Human cytomegalovirus infection,4/225,0.4913555102168229,0.8739887965081903,0,0,1.1074304903383705,0.7869261082838809,NFATC3;ITPR2;KRAS;CRK
GO_Biological_Process_2021,Protein digestion and absorption,2/103,0.4959084650493602,0.8739887965081903,0,0,1.21144801980198,0.8496659266650215,SLC7A8;MEP1A
GO_Biological_Process_2021,Pathways of neurodegeneration,8/475,0.4987202220925928,0.8739887965081903,0,0,1.0480775787994927,0.729158070832578,RYR1;CASP7;MAP3K10;ITPR2;KRAS;MCU;MAP3K5;BCL2L1
GO_Biological_Process_2021,T cell receptor signaling pathway,2/104,0.5010224795302838,0.8739887965081903,0,0,1.1995098039215686,0.8289863948759917,NFATC3;KRAS
GO_Biological_Process_2021,Wnt signaling pathway,3/166,0.5016661206464981,0.8739887965081903,0,0,1.1259303421351232,0.7766898077973522,ZNRF3;CTBP2;NFATC3
GO_Biological_Process_2021,Fatty acid degradation,1/43,0.5027548166802547,0.8739887965081903,0,0,1.45646046580626,1.0015389276364557,ECI1
GO_Biological_Process_2021,cGMP-PKG signaling pathway,3/167,0.5056743965235848,0.8739887965081903,0,0,1.1190075693860386,0.763009077162542,NPR2;NFATC3;ITPR2
GO_Biological_Process_2021,Vasopressin-regulated water reabsorption,1/44,0.5107776942804749,0.8739887965081903,0,0,1.422516844164312,0.955676438376224,RAB5B
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",2/106,0.5111500560429959,0.8739887965081903,0,0,1.1763221153846153,0.7894204553259379,ITPR2;ARRB2
GO_Biological_Process_2021,Glucagon signaling pathway,2/107,0.5161631294690595,0.8739887965081903,0,0,1.1650595238095238,0.7704916355846029,ITPR2;PFKP
GO_Biological_Process_2021,Glycosphingolipid biosynthesis,1/45,0.5186715206871735,0.8739887965081903,0,0,1.39011611441518,0.9125896882973232,ST6GALNAC3
GO_Biological_Process_2021,Other types of O-glycan biosynthesis,1/47,0.5340802646758471,0.8739887965081903,0,0,1.3295408370581066,0.8339001689088014,GALNT1
GO_Biological_Process_2021,Pyruvate metabolism,1/47,0.5340802646758471,0.8739887965081903,0,0,1.3295408370581066,0.8339001689088014,ME3
GO_Biological_Process_2021,Chemical carcinogenesis,4/239,0.5386790186175552,0.8739887965081903,0,0,1.0407065435568046,0.6438179070140505,RPS6KA6;HPGDS;KRAS;ARRB2
GO_Biological_Process_2021,TNF signaling pathway,2/112,0.540713021817561,0.8739887965081903,0,0,1.1118181818181818,0.6836198648571832,CASP7;MAP3K5
GO_Biological_Process_2021,Cholinergic synapse,2/113,0.5455186872079203,0.8739887965081903,0,0,1.1017454954954955,0.6676778410647004,ITPR2;KRAS
GO_Biological_Process_2021,Alzheimer disease,6/369,0.5474285437687515,0.8739887965081903,0,0,1.0103044251490745,0.6087319961256865,CASP7;ITPR2;KRAS;IDE;MCU;MAP3K5
GO_Biological_Process_2021,Ether lipid metabolism,1/49,0.5489972106461568,0.8739887965081903,0,0,1.2740134994807892,0.7639773790078593,PLA2G4C
GO_Biological_Process_2021,Sphingolipid metabolism,1/49,0.5489972106461568,0.8739887965081903,0,0,1.2740134994807892,0.7639773790078593,ACER2
GO_Biological_Process_2021,Glutamatergic synapse,2/114,0.5502892422458976,0.8739887965081903,0,0,1.0918526785714286,0.6521758816993809,PLA2G4C;ITPR2
GO_Biological_Process_2021,Malaria,1/50,0.5562761693049759,0.8770485589041956,0,0,1.2479496471485791,0.7319104885681406,GYPC
GO_Biological_Process_2021,Ovarian steroidogenesis,1/51,0.5634380078434723,0.8811029560744801,0,0,1.2229283489096574,0.7015915041983243,PLA2G4C
GO_Biological_Process_2021,Parkinson disease,4/249,0.5710852493075333,0.8811029560744801,0,0,0.9977153125401104,0.5589368619509928,ITPR2;MCU;MAP3K5;BCL2L1
GO_Biological_Process_2021,Salmonella infection,4/249,0.5710852493075333,0.8811029560744801,0,0,0.9977153125401104,0.5589368619509928,RAB5B;CASP7;PLEKHM2;PIK3C2B
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,1/53,0.5774178090335665,0.8845549414982296,0,0,1.1757728253055355,0.6457217005504277,B4GALT7
GO_Biological_Process_2021,Thyroid hormone signaling pathway,2/121,0.5826916793145733,0.886347906563013,0,0,1.0272584033613446,0.554819268653507,KRAS;PFKP
GO_Biological_Process_2021,Legionellosis,1/57,0.6040526461249386,0.912415185755152,0,0,1.0915665331553182,0.5502520552449066,CASP7
GO_Biological_Process_2021,Osteoclast differentiation,2/127,0.6090740667969166,0.9136111001953748,0,0,0.97765,0.4847339241589555,CSF1R;SIRPA
GO_Biological_Process_2021,Lysosome,2/128,0.6133460172610538,0.9136740670923283,0,0,0.9698412698412698,0.4740836644013557,AP4E1;CTSC
GO_Biological_Process_2021,Oocyte meiosis,2/129,0.6175822718858668,0.9136833611462138,0,0,0.9621555118110235,0.4637040999078665,RPS6KA6;ITPR2
GO_Biological_Process_2021,Dopaminergic synapse,2/132,0.6300772848832137,0.9157137196348522,0,0,0.9398076923076925,0.4341091957572792,ITPR2;ARRB2
GO_Biological_Process_2021,Focal adhesion,3/201,0.6309218451117319,0.9157137196348522,0,0,0.9252398594091384,0.4261407595078475,RAP1A;ITGA5;CRK
GO_Biological_Process_2021,Basal cell carcinoma,1/63,0.6408994087743389,0.9157137196348522,0,0,0.985629584966335,0.4384896130200874,DDB2
GO_Biological_Process_2021,Insulin signaling pathway,2/137,0.6501934831342746,0.9157137196348522,0,0,0.9047685185185184,0.3894895417197981,KRAS;CRK
GO_Biological_Process_2021,Cortisol synthesis and secretion,1/65,0.6524055586142272,0.9157137196348522,0,0,0.954731308411215,0.4077551328641531,ITPR2
GO_Biological_Process_2021,Measles,2/139,0.657993752923538,0.9157137196348522,0,0,0.8914689781021898,0.3731331143897384,TLR7;BCL2L1
GO_Biological_Process_2021,Aminoacyl-tRNA biosynthesis,1/66,0.6580200546866074,0.9157137196348522,0,0,0.9399952072849268,0.3934066718352108,CARS2
GO_Biological_Process_2021,Signaling pathways regulating pluripotency of stem cells,2/143,0.6731767285835033,0.9157137196348522,0,0,0.8660017730496454,0.3427179376248223,KRAS;SKIL
GO_Biological_Process_2021,Renin secretion,1/69,0.6743268587276872,0.9157137196348522,0,0,0.8983873923401137,0.354000866360204,ITPR2
GO_Biological_Process_2021,PI3K-Akt signaling pathway,5/354,0.6769539792547861,0.9157137196348522,0,0,0.8735639456581671,0.3408227081633254,CSF1R;TGFA;KRAS;ITGA5;BCL2L1
GO_Biological_Process_2021,Prolactin signaling pathway,1/70,0.6795883263811009,0.9157137196348522,0,0,0.8853221364395684,0.3419716698922899,KRAS
GO_Biological_Process_2021,Breast cancer,2/147,0.6878095174521285,0.9157137196348522,0,0,0.8419396551724138,0.315090311620044,KRAS;DDB2
GO_Biological_Process_2021,Gastric cancer,2/149,0.694922343082203,0.9157137196348522,0,0,0.8303996598639456,0.3022282545493652,KRAS;DDB2
GO_Biological_Process_2021,PPAR signaling pathway,1/74,0.699800262779992,0.9157137196348522,0,0,0.8366406350019203,0.2986475117581206,ME3
GO_Biological_Process_2021,Thyroid hormone synthesis,1/75,0.7046514052506102,0.9157137196348522,0,0,0.8252925823019281,0.288895367789195,ITPR2
GO_Biological_Process_2021,Phagosome,2/152,0.7053405279680113,0.9157137196348522,0,0,0.8136666666666666,0.2840303453631037,RAB5B;ITGA5
GO_Biological_Process_2021,Gastric acid secretion,1/76,0.7094243936169427,0.9157137196348522,0,0,0.8142471443406023,0.2795321446739909,ITPR2
GO_Biological_Process_2021,Metabolism of xenobiotics by cytochrome P450,1/76,0.7094243936169427,0.9157137196348522,0,0,0.8142471443406023,0.2795321446739909,HPGDS
GO_Biological_Process_2021,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.7141204831971915,0.9157137196348522,0,0,0.8034923757993113,0.2705387649820932,ITGA5
GO_Biological_Process_2021,Cushing syndrome,2/155,0.7154613520158741,0.9157137196348522,0,0,0.7975898692810458,0.267055178919348,RAP1A;ITPR2
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,2/155,0.7154613520158741,0.9157137196348522,0,0,0.7975898692810458,0.267055178919348,CASP7;MAP3K5
GO_Biological_Process_2021,Antigen processing and presentation,1/78,0.7187409091061258,0.9157137196348522,0,0,0.7930169518954566,0.2618972862114995,NFYC
GO_Biological_Process_2021,Thermogenesis,3/232,0.7244952978675964,0.9157137196348522,0,0,0.7987159655583086,0.2574101873052556,RPS6KA6;KRAS;MAP3K5
GO_Biological_Process_2021,Necroptosis,2/159,0.7285012657976522,0.9157137196348522,0,0,0.7771098726114649,0.2461619204817633,PLA2G4C;TICAM1
GO_Biological_Process_2021,Peroxisome,1/82,0.7364899931635095,0.9157137196348522,0,0,0.7537017807007422,0.2305269479161704,PEX13
GO_Biological_Process_2021,MicroRNAs in cancer,4/310,0.7381644720666837,0.9157137196348522,0,0,0.7963168495909895,0.2417527313260672,KRAS;ITGA5;CRK;RECK
GO_Biological_Process_2021,ECM-receptor interaction,1/88,0.7610416533446318,0.9157137196348522,0,0,0.701507501700863,0.1915586805737558,ITGA5
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,1/90,0.7687077706623352,0.9157137196348522,0,0,0.6856732822289895,0.1803625128975873,ITGA5
GO_Biological_Process_2021,Morphine addiction,1/91,0.7724483837777466,0.9157137196348522,0,0,0.6780200761509173,0.1750580641840596,ARRB2
GO_Biological_Process_2021,Salivary secretion,1/93,0.7797496452591561,0.9157137196348522,0,0,0.6632127861302993,0.1649956543427259,ITPR2
GO_Biological_Process_2021,Human papillomavirus infection,4/331,0.7828436467723121,0.9157137196348522,0,0,0.7443694343469314,0.1822382278616932,MAML2;KRAS;ITGA5;TICAM1
GO_Biological_Process_2021,TGF-beta signaling pathway,1/94,0.7833122170121886,0.9157137196348522,0,0,0.6560479683783874,0.1602226051553093,SMURF1
GO_Biological_Process_2021,Tuberculosis,2/180,0.7889057751038476,0.9157137196348522,0,0,0.6846910112359551,0.1623459822650273,RAB5B;NFYC
GO_Biological_Process_2021,Dilated cardiomyopathy,1/96,0.7902659358435117,0.9157137196348522,0,0,0.6421708476799476,0.151157874647609,ITGA5
GO_Biological_Process_2021,Circadian entrainment,1/97,0.7936589153442403,0.9157137196348522,0,0,0.6354491173416407,0.1468532363638695,RYR1
GO_Biological_Process_2021,Aldosterone synthesis and secretion,1/98,0.7969971719163798,0.9157137196348522,0,0,0.6288659793814433,0.1426922996408902,ITPR2
GO_Biological_Process_2021,Glycerophospholipid metabolism,1/98,0.7969971719163798,0.9157137196348522,0,0,0.6288659793814433,0.1426922996408902,PLA2G4C
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,1/100,0.8035130220239355,0.9157137196348522,0,0,0.6160986815192423,0.1347789103383304,KRAS
GO_Biological_Process_2021,Viral protein interaction with cytokine and cytokine receptor,1/100,0.8035130220239355,0.9157137196348522,0,0,0.6160986815192423,0.1347789103383304,CSF1R
GO_Biological_Process_2021,Melanogenesis,1/101,0.8066923331309016,0.9157137196348522,0,0,0.6099065420560748,0.1310158119807761,KRAS
GO_Biological_Process_2021,Amoebiasis,1/102,0.8098203571774681,0.9157137196348522,0,0,0.6038370192159402,0.1273750940247891,RAB5B
GO_Biological_Process_2021,Chagas disease,1/102,0.8098203571774681,0.9157137196348522,0,0,0.6038370192159402,0.1273750940247891,TICAM1
GO_Biological_Process_2021,Neutrophil extracellular trap formation,2/189,0.8109636880990891,0.9157137196348522,0,0,0.6514371657754011,0.1364969322841276,SELPLG;TLR7
GO_Biological_Process_2021,Prion disease,3/273,0.8185546447235118,0.9157137196348522,0,0,0.6760013932427725,0.1353457016683926,RYR1;ITPR2;MCU
GO_Biological_Process_2021,Th17 cell differentiation,1/107,0.8247195811464381,0.9157137196348522,0,0,0.5752071944983248,0.1108492437744915,NFATC3
GO_Biological_Process_2021,Drug metabolism,1/108,0.8275567480937803,0.9157137196348522,0,0,0.5698023117011675,0.1078508119394714,HPGDS
GO_Biological_Process_2021,Insulin resistance,1/108,0.8275567480937803,0.9157137196348522,0,0,0.5698023117011675,0.1078508119394714,RPS6KA6
GO_Biological_Process_2021,HIF-1 signaling pathway,1/109,0.8303481311983165,0.9157137196348522,0,0,0.5644975193261798,0.1049458641892783,PFKP
GO_Biological_Process_2021,Toxoplasmosis,1/112,0.8384548838878213,0.9157137196348522,0,0,0.5491566332687828,0.0967583811143571,BCL2L1
GO_Biological_Process_2021,Epstein-Barr virus infection,2/202,0.8392029065413431,0.9157137196348522,0,0,0.6086875,0.1067045977774861,NEDD4;DDB2
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,4/364,0.8405999127280263,0.9157137196348522,0,0,0.6749825296995108,0.1172036021231711,NUP188;MCU;MAP3K5;BCL2L1
GO_Biological_Process_2021,Viral carcinogenesis,2/203,0.8412092200253668,0.9157137196348522,0,0,0.6056281094527363,0.1047221086311001,GSN;KRAS
GO_Biological_Process_2021,Leukocyte transendothelial migration,1/114,0.8436436583672943,0.9157137196348522,0,0,0.5393819094092024,0.0917084519019823,RAP1A
GO_Biological_Process_2021,AMPK signaling pathway,1/120,0.858234055914347,0.9268927803874948,0,0,0.5120291107097045,0.0782782036176319,PFKP
GO_Biological_Process_2021,cAMP signaling pathway,2/216,0.8653037821945095,0.9273015669642508,0,0,0.5684579439252336,0.0822414486288516,RAP1A;ARAP3
GO_Biological_Process_2021,Cell cycle,1/124,0.8671986876239752,0.9273015669642508,0,0,0.4952764480915837,0.0705705353189979,CDC14B
GO_Biological_Process_2021,Huntington disease,3/306,0.873071611556022,0.9288507242968632,0,0,0.6013532387721531,0.0816263038545132,MAP3K10;NRF1;MAP3K5
GO_Biological_Process_2021,FoxO signaling pathway,1/131,0.8815481411150786,0.9288507242968632,0,0,0.4684399712437095,0.0590588813146821,KRAS
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,1/131,0.8815481411150786,0.9288507242968632,0,0,0.4684399712437095,0.0590588813146821,KRAS
GO_Biological_Process_2021,Coronavirus disease,2/232,0.8903506166910952,0.933571520413964,0,0,0.5284782608695652,0.0613774348278285,NRP1;TLR7
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,1/139,0.8960641029047143,0.9350234117266584,0,0,0.4411034358210303,0.0484081577802699,MAP3K5
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,1/148,0.9102850439402942,0.9407270443899882,0,0,0.4139063725178545,0.0389061615271969,ITPR2
GO_Biological_Process_2021,Spliceosome,1/150,0.9131718087503808,0.9407270443899882,0,0,0.4083087666478496,0.0370871897978412,RP9
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,3/341,0.9145957376013776,0.9407270443899882,0,0,0.538109105748363,0.048038683164509,CYSLTR1;P2RX1;PTAFR
GO_Biological_Process_2021,JAK-STAT signaling pathway,1/162,0.92864799925472,0.9506538760143104,0,0,0.3776436214469534,0.0279552634951819,BCL2L1
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,1/171,0.9384211686062534,0.956127228391277,0,0,0.3574857980575407,0.0227205188504,MAP3K5
GO_Biological_Process_2021,Alcoholism,1/186,0.9518337648219848,0.9614922481125414,0,0,0.3282478740422666,0.0162039156721283,KRAS
GO_Biological_Process_2021,Cytokine-cytokine receptor interaction,2/295,0.9525895421114996,0.9614922481125414,0,0,0.4135025597269625,0.0200843026829597,CSF1R;EDA2R
GO_Biological_Process_2021,Diabetic cardiomyopathy,1/203,0.96354710783577,0.96802872229082,0,0,0.3003608772092162,0.0111535707524355,MPC1
GO_Biological_Process_2021,Olfactory transduction,1/440,0.9992666667065944,0.9992666667065944,0,0,0.1365252379026249,0.00010015523041669064,ARRB2
